Antiseizure Medications

ASM Reference is the definitive clinical companion for anti-seizure medications, designed for neurologists, epileptologists, neurology trainees, and healthcare professionals managing epilepsy. Covering 24 anti-seizure medications across three generations and six drug classes, ASM Reference brings together everything you need at the point of care from dosing and mechanisms to interactions, pregnancy safety, and monitoring requirements. WHAT'S INSIDE • Full drug profiles for 18 ASMs including Levetiracetam, Lamotrigine, Sodium Valproate, Carbamazepine, Lacosamide, Topiramate, Phenytoin, Oxcarbazepine, Brivaracetam, Perampanel, and more • Detailed dosing for adults, paediatrics, and IV administration including status epilepticus protocols • Drug interaction checker covering major, moderate, and minor interactions with clinical explanations • Pregnancy safety guide with evidence-based categories, teratogenicity data, MHRA warnings, and breastfeeding information • Renal and hepatic dose adjustment tables for every medication • Monitoring requirements including blood tests, drug levels, and clinical surveillance • Side-by-side comparison of all medications by spectrum, pregnancy category, enzyme effects, and drug level availability • Mechanism of action for each drug class • Instant search by drug name, brand name, or drug class EVIDENCE-BASED Built on current NICE guidelines, EURAP and NEAD cohort data, IHS 2022 guidelines, and up-to-date neuropharmacology evidence. Includes MHRA Black Box warnings and Valproate Pregnancy Prevention Programme (VAPP) guidance. DESIGNED FOR CLINICAL USE Clean, fast, and intuitive interface designed for busy clinical environments. Full offline access — no internet connection required at the point of care. ASM Reference is intended as a clinical reference tool for qualified healthcare professionals. This application is intended for educational and informational purposes only. It is not a substitute for professional clinical judgment, local guidelines, or specialist advice. Always follow institutional protocols and consult appropriate medical professionals when making treatment decisions.